Impact of alcohol use disorder severity on human immunodeficiency virus (HIV) viral suppression and CD4 count in three international cohorts of people with HIV.

BACKGROUND Alcohol use has been linked to worse human immunodeficiency virus (HIV) immunologic/virologic outcomes, yet few studies have explored the effects of alcohol use disorder (AUD). This study assessed whether AUD severity is associated with HIV viral suppression and CD4 count in the three cohorts of the Uganda Russia Boston Alcohol Network for Alcohol Research Collaboration on HIV/AIDS (URBAN ARCH) Consortium. METHODS People with HIV (PWH) in Uganda (n = 301), Russia (n = 400), and Boston (n = 251), selected in-part based on their alcohol use, were included in analyses. Logistic and linear regressions were used to assess the cross-sectional associations between AUD severity (number of DSM-5 diagnostic criteria) and (1) HIV viral suppression, and (2) CD4 count (cells/mm3 ) adjusting for covariates. Analyses were conducted separately by site. RESULTS The proportion of females was 51% (Uganda), 34% (Russia), and 33% (Boston); mean age (SD) was 40.7 (9.6), 38.6 (6.3), and 52.1 (10.5), respectively. All participants in Uganda and all but 27% in Russia and 5% in Boston were on antiretroviral therapy. In Uganda, 32% met criteria for AUD, 92% in Russia, and 43% in Boston. The mean (SD) number of AUD criteria was 1.6 (2.4) in Uganda, 5.6 (3.3) in Russia, and 2.4 (3.1) in Boston. Most participants had HIV viral suppression (Uganda 92%, Russia 57%, Boston 87%); median (IQR) CD4 count was 673 (506, 866), 351 (201, 542), and 591 (387, 881), respectively. In adjusted models, there were no associations between AUD severity and HIV viral suppression: adjusted odds ratios (AOR) (95%CI) per 1 additional AUD criterion in Uganda was 1.08 (0.87, 1.33); Russia 0.98 (0.92, 1.04); and Boston 0.95 (0.84, 1.08) or CD4 count: mean difference (95%CI) per 1 additional criterion: 5.78 (-7.47, 19.03), -3.23 (-10.91, 4.44), and -8.18 (-24.72, 8.35), respectively. CONCLUSIONS In three cohorts of PWH, AUD severity was not associated with HIV viral suppression or CD4 count. PWH with AUD in the current era of antiretroviral therapy can achieve virologic control.

[1]  M. Winter,et al.  Design of a randomized controlled trial of smoking cessation medications for alcohol reduction among HIV-positive heavy drinkers and daily smokers in St. Petersburg, Russia , 2020, Contemporary clinical trials communications.

[2]  M. Ayalew,et al.  The prevalence of alcohol use disorders among people living with HIV/AIDS: a systematic review and meta-analysis , 2019, Substance Abuse Treatment, Prevention, and Policy.

[3]  Brandon D. L. Marshall,et al.  Changes in alcohol use associated with changes in HIV disease severity over time: A national longitudinal study in the Veterans Aging Cohort. , 2018, Drug and alcohol dependence.

[4]  Brandon D. L. Marshall,et al.  Level of Alcohol Use Associated with HIV Care Continuum Targets in a National U.S. Sample of Persons Living with HIV Receiving Healthcare , 2018, AIDS and Behavior.

[5]  S. Tarima,et al.  Predictors of HIV Care Engagement, Antiretroviral Medication Adherence, and Viral Suppression Among People Living with HIV Infection in St. Petersburg, Russia , 2018, AIDS and Behavior.

[6]  T. Heeren,et al.  Polypharmacy and risk of falls and fractures for patients with HIV infection and substance dependence , 2018, AIDS care.

[7]  T. Heeren,et al.  HIV-infected individuals who use alcohol and other drugs, and virologic suppression , 2017, AIDS care.

[8]  Cláudio Moss da Silva,et al.  Alcohol use disorders among people living with HIV/AIDS in Southern Brazil: prevalence, risk factors and biological markers outcomes , 2017, BMC Infectious Diseases.

[9]  J. Rehm,et al.  Does alcohol use have a causal effect on HIV incidence and disease progression? A review of the literature and a modeling strategy for quantifying the effect , 2017, Population Health Metrics.

[10]  Joseph E. Glass,et al.  Psychosocial stressors and alcohol use, severity, and treatment receipt across human immunodeficiency virus (HIV) status in a nationally representative sample of US residents , 2017, Substance abuse.

[11]  E. Williams,et al.  Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. , 2016, Alcoholism, clinical and experimental research.

[12]  B. Agan,et al.  Characterizing the Association Between Alcohol and HIV Virologic Failure in a Military Cohort on Antiretroviral Therapy. , 2016, Alcoholism, clinical and experimental research.

[13]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[14]  F. Altice,et al.  A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. , 2010, Drug and alcohol dependence.

[15]  J. Hahn,et al.  Alcohol and HIV Disease Progression: Weighing the Evidence , 2010, Current HIV/AIDS reports.

[16]  K. Freedberg,et al.  Discontinuation From HIV Medical Care: Squandering Treatment Opportunities , 2010, Journal of health care for the poor and underserved.

[17]  J. Bell,et al.  Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders , 2009, AIDS care.

[18]  J. Parsons,et al.  The temporal relationship between alcohol consumption and HIV-medication adherence: a multilevel model of direct and moderating effects. , 2008, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[19]  Richard D Moore,et al.  Hazardous Alcohol Use: A Risk Factor for Non-Adherence and Lack of Suppression in HIV Infection , 2006, Journal of acquired immune deficiency syndromes.

[20]  R. Frankowski,et al.  Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure , 2005, AIDS care.

[21]  Richard D Moore,et al.  Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic , 2002, AIDS.

[22]  K. Freedberg,et al.  Understanding delay to medical care for HIV infection: the long-term non-presenter , 2001, AIDS.

[23]  K. Freedberg,et al.  Trillion virion delay: time from testing positive for HIV to presentation for primary care. , 1998, Archives of internal medicine.

[24]  E. Hudes,et al.  Alcohol-related risk factors associated with HIV infection among patients entering alcoholism treatment: implications for prevention. , 1995, Journal of studies on alcohol.

[25]  R. Freeman.  Toward Development of Enhanced Preventive Interventions for HIV Sexual Risk among Alcohol-Using Populations: Confronting the ‘Mere Pause from Thinking’ , 2015, AIDS and Behavior.

[26]  Derenik Gharibian,et al.  Comparison of HIV Virologic Failure Rates Between Patients with Variable Adherence to Three Antiretroviral Regimen Types. , 2015, AIDS patient care and STDs.

[27]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.